ConectX (“Con-NEX”) provides an exciting new opportunity for drug development.
ConectX offers Comparative Neuro Oncology Trials in dogs, as models for human disease
Why this collaboration?
The Veterinary Clinical Research Network (VCRN) is a network of GP veterinary clinics and specialist veterinary hospitals around Australia, who cooperate in clinical research trials with Invetus.
VCRN has been undertaking trials for three years in Australia. We work very closely with veterinary specialist oncologists, neurologists, internists and surgeons who have expertise in chemotherapy, radiotherapy and surgery to treat various cancers. This includes both private hospitals, which make up the majority of our network, but also the three largest veterinary university teaching hospitals in Australia.
Through our network, it is possible to recruit cases of cancer in dogs and cats, when they present to their local vet or animal hospital.
Using pets for pilot and exploratory studies has unique advantages which aren’t possible in human trials. Once animal ethics requirements are met, the decision to treat, partially treat or euthanase an animal with cancer is largely up to the owner and the veterinarian. This allows a variety of experimental molecules to be offered for such pets, since there are few other good options for treatment.
Cost to pet owners can also be an important factor; if there are limited options for standard therapy, the owner may choose to try an experimental treatment, and there may be only minimal costs associated with this option.
Trials are conducted according to Good Clinical Practice (GCP) requirements; this quality standard is important for registration of medicines in humans
CSIRO/UQ have advanced imaging capabilities in both dogs and humans
CSIRO offers research expertise in genomics, informatics, diagnostics and other expertise for both humans and pets
For further information, please contact:
Prof Stephen Rose
Probing Biosystems Future Science Platform Leader
p: +61 7 3253 3620
m: +61 (0) 477 761 175
Dr Elizabeth Evans
Director, Business Development
m: +61 (0) 409 703 412
Dr Simon Puttick
CSIRO-AIBN Research Fellow
Australian Institute for Bioengineering and Nanotechnology
p: +61 7 334 63849